VIRTUAL KOL EVENT
The Potential Role of Anti-OX40/OX40L Monoclonal Antibodies (mAbs) in the Treatment of Alopecia Areata (AA)
Wednesday, May 28th, 2025 | 11:00AM ET
Designed to be different:
Developing a potential best-in-class anti-OX40 treatment with features that matter to patients
ImageneBio is a clinical-stage biotechnology company developing therapeutics for patients who have immunological, autoimmune and inflammatory diseases. IMG-007 is our next-generation investigational anti-OX40 monoclonal antibody.
IMG-007
IMG-007 is an extended half-life anti-OX40 monoclonal antibody in clinical development that targets and inhibits OX40 receptor signaling without depleting T cells for potential enhanced efficacy, safety, and patient convenience.
News
Access Denied
You don't have permission to access "http://clientapi.gcs-web.com/data/d0ebe5d3-dfbe-4782-9f81-ac7a4672590d/news?" on this server.Reference #18.174e4317.1778147598.397438fa
https://errors.edgesuite.net/18.174e4317.1778147598.397438fa
[response] => Array ( [code] => 403 [message] => Forbidden ) [cookies] => Array ( ) [filename] => [http_response] => WP_HTTP_Requests_Response Object ( [data] => [headers] => [status] => [response:protected] => WpOrg\Requests\Response Object ( [body] =>Access Denied
You don't have permission to access "http://clientapi.gcs-web.com/data/d0ebe5d3-dfbe-4782-9f81-ac7a4672590d/news?" on this server.Reference #18.174e4317.1778147598.397438fa
https://errors.edgesuite.net/18.174e4317.1778147598.397438fa
[raw] => HTTP/1.1 403 Forbidden Server: AkamaiGHost Mime-Version: 1.0 Content-Type: text/html Content-Length: 454 X-Reference-Error: 18.174e4317.1778147598.397438fa Cache-Control: max-age=0 Expires: Thu, 07 May 2026 09:53:18 GMT Date: Thu, 07 May 2026 09:53:18 GMT Connection: closeAccess Denied
You don't have permission to access "http://clientapi.gcs-web.com/data/d0ebe5d3-dfbe-4782-9f81-ac7a4672590d/news?" on this server.Reference #18.174e4317.1778147598.397438fa
https://errors.edgesuite.net/18.174e4317.1778147598.397438fa
[headers] => WpOrg\Requests\Response\Headers Object ( [data:protected] => Array ( [server] => Array ( [0] => AkamaiGHost ) [mime-version] => Array ( [0] => 1.0 ) [content-type] => Array ( [0] => text/html ) [content-length] => Array ( [0] => 454 ) [x-reference-error] => Array ( [0] => 18.174e4317.1778147598.397438fa ) [cache-control] => Array ( [0] => max-age=0 ) [expires] => Array ( [0] => Thu, 07 May 2026 09:53:18 GMT ) [date] => Array ( [0] => Thu, 07 May 2026 09:53:18 GMT ) ) ) [status_code] => 403 [protocol_version] => 1.1 [success] => [redirects] => 0 [url] => https://clientapi.gcs-web.com/data/d0ebe5d3-dfbe-4782-9f81-ac7a4672590d/news?size=3 [history] => Array ( ) [cookies] => WpOrg\Requests\Cookie\Jar Object ( [cookies:protected] => Array ( ) ) ) [filename:protected] => ) )